In conclusion, PMFs exerted an anti-inflammatory effect in AD-like mice by mitigating microglial activation, downregulating the expression of pro-inflammatory cytokines (TNF-α and IL-1β) and upregulating the expression of anti-inflammatory cytokines (IL-10 and TGF-β). Here, IL1B is linked to Alzheimer disease.